MyFinsight

HomeCompareAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Privacy Policy
  • Contact

Follow Us

  • Thread
  • X.com
  • Instagram

© 2026 MyFinsight. All rights reserved.

Recent SEC Filings
10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)10/6Lamb Weston Holdings, Inc.(LW)10/2NIKE, Inc.(NKE)10/2DARDEN RESTAURANTS INC(DRI)9/30CONAGRA BRANDS INC.(CAG)9/29Carnival Corp Ltd.(CCL)9/29URANIUM ENERGY CORP(UEC)9/29COPART INC(CPRT)9/24BLACKBERRY Ltd(BB)9/24PAYCHEX INC(PAYX)9/23GENERAL MILLS INC(GIS)9/22ADOBE INC.(ADBE)9/18KROGER CO(KR)
||
||

Income Overview

Net Income
-$88,409K
EPS
-$1.63
Unit: Thousand (K) dollars
Income Statement
2026-06-30
2026-03-31
Research and development
75,460
70,047
General and administrative
17,934
17,290
Total operating expenses
93,394
87,337
Loss from operations
-93,394
-87,337
Interest income (expense), net
5,037
4,380
Other income (expense), net
-52
-1
Net loss and comprehensive loss
-88,409
-82,958
Net loss attributable to common stockholders
-88,409
-82,958
Basic EPS
-1.63
-2.46
Diluted EPS
-1.63
-2.46
Basic Average Shares
54,143,162
33,700,550
Diluted Average Shares
54,143,162
33,700,550
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

EIKN Income Statement Sankey DiagramSankey diagram visualizing EIKN income statement for the periodNet lossattributable to common...-$88,409K Net loss andcomprehensive loss-$88,409K Interest income(expense), net$5,037K Loss from operations-$93,394K Other income(expense), net-$52K Total operatingexpenses$93,394K Research and development$75,460K General andadministrative$17,934K

Eikon Therapeutics, Inc. (EIKN)

Eikon Therapeutics, Inc. (EIKN)